Your browser does not support SVG.
Board of Directors
November 20, 2015
Licensing of RVT-501 ...
Dermavant Named One of Fortune® Magazine’s 2020 “100 Best Small and Medium Companies to Work For”
Dermavant’s Pivotal Phase 3 PSOARING Data for Tapinarof Cream in Adults with Plaque Psoriasis Selected as Late-Breaking Oral Presentation at the 29th European Academy of Dermatology and Venereology (EADV) Virtual Congress
Dermavant Announces Presentation of Tapinarof Pivotal Phase 3 PSOARING Data at Fall Clinical Dermatology Conference
Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis
Dermavant Announces Publication in JAAD of Secondary Efficacy and Patient-Reported Outcomes in Phase 2b Clinical Trial of Tapinarof Cream for the Treatment of Atopic Dermatitis